(Self-) infections with parasites: Re-interpretations for the present

Trends in Parasitology

Volumn 30, Issue 8, 2014, Pages 377-385

  Lukeš, Julius ^a,b   Kuchta, Roman ^a   Scholz, Tomáš ^a,b   Pomajbíková, Kateřina ^a  

^a INSTITUTE OF PARASITOLOGY   (Czech Republic)

^b UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

Author keywords

Autoimmune diseases; Helminth therapy; Helminths; Protists; Self infection; Volunteers

Indexed keywords

ARTICLE; DISEASE TRANSMISSION; HELMINTH; HELMINTHIASIS; HOST RANGE; HUMAN; IMMUNE RESPONSE; PARASITOSIS; PATHOGENICITY; PROTIST;

PROTISTA; VERMES;

AUTOIMMUNE DISEASES; HELMINTH THERAPY; HELMINTHS; PROTISTS; SELF-INFECTION; VOLUNTEERS;

ANIMALS; AUTOIMMUNE DISEASES; ETHICS, MEDICAL; EUKARYOTA; HELMINTHS; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNE SYSTEM PHENOMENA; PARASITIC DISEASES;

EID: 84904760134     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2014.06.005     Document Type: Review

References (86)

1. Yemaneberhan H., et al. Prevalence of wheeze and asthma and relation to atopy in urban and rural Ethiopia. Lancet 1997, 350:85-90.
2. Yazdanbakhsh M., et al. Immunology: allergy, parasites, and the hygiene hypothesis. Science 2002, 296:490-494.
3. Wiria A.E., et al. Helminth infection in populations undergoing epidemiological transition: a friend or foe?. Semin. Immunopathol. 2012, 34:889-901.
4. Wiria A.E., et al. Relationship between carotid intima media thickness and helminth infections on Flores Island, Indonesia. PLoS ONE 2013, 8:e54855.
5. Falcone F.H., Pritchard D.I. Parasite role reversal: worms on trial. Trends Parasitol. 2005, 21:157-160.
6. McSorley H.J., et al. Immunomodulation by helminth parasites: defining mechanisms and mediators. Int. J. Parasitol. 2013, 43:301-310.
7. Shor D.B., et al. The hygiene theory harnessing helminths and their ova to treat autoimmunity. Clin. Rev. Allergy Immunol. 2013, 45:211-216.
8. Wakelin D. Immunity to Parasites. How Parasitic Infections are Controlled 1996, Cambridge University Press.
9. Cooper P.J. Intestinal worms and human allergy. Parasite Immunol. 2004, 26:455-467.
10. Cooper P.J., et al. Human allergy and geohelminth infections: a review of the literature and a proposed conceptual model to guide the investigation of possible causal associations. Brit. Med. Bull. 2006, 79-80:203-218.
11. Flohr C., et al. Regular antihelminthic therapy increases allergen skin sensitization: a randomized, double-blind, placebo-controlled trial in Vietnam. Br. J. Dermatol. 2008, 159:1242.
12. Pritchard D.I., et al. Parasitic worm therapy for allergy: is this incongruous or avant-garde medicine?. Clin. Exp. Allergy 2012, 42:505-512.
13. Strachan D.P. Hay-fever, hygiene, and household size. Br. Med. J. 1989, 299:1259-1260.
14. Croese J., et al. A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors. Gut 2006, 55:136-137.
15. Croese J., et al. Changed gluten immunity in celiac disease by Necator americanus provides new insights into autoimmunity. Int. J. Parasitol. 2013, 43:275-282.
16. Summers R.W., et al. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 2005, 128:825-832.
17. Weinstock J.V. The worm returns. Nature 2012, 491:183-185.
18. Weinstock J.V., Elliott D.E. Translatability of helminth therapy in inflammatory bowel diseases. Int. J. Parasitol. 2013, 43:245-251.
19. Fleming J.O. Helminth therapy and multiple sclerosis. Int. J. Parasitol. 2013, 43:259-274.
20. Siniscalco D., Antonucci N. Possible use of Trichuris suis ova in autism spectrum disorders therapy. Med. Hypotheses 2013, 81:1-4.
21. Jouvin M.H., Kinet J.P. Trichuris suis ova: testing a helminth-based therapy as an extension of the hygiene hypothesis. J. Allergy Clin. Immunol. 2012, 130:3-12.
22. Zaccone P., Cooke A. Helminth mediated modulation of Type 1 diabetes (T1D). Int. J. Parasitol. 2013, 43:311-318.
23. Nyberg W., et al. Serum vitamin B12 levels and incidence of tapeworm anemia in a population heavily infected with Diphyllobothrium latum. Am. J. Clin. Nutr. 1961, 9:606-612.
24. Rendtorff R.C. The experimental transmission of human intestinal protozoan parasites. 1. Endamoeba coli cysts given in capsules. Am. J. Hyg. 1954, 59:196-208.
25. Rendtorff R.C. The experimental transmission of human intestinal protozoan parasites. 2. Giardia lamblia cysts given in capsules. Am. J. Hyg. 1954, 59:209-220.
26. Brumpt E. Precis de Parasitologie 1910, Masson et Cie.
27. Taute M., Huber F. Die Unterscheidung des Trypanosoma rhodesiense vom Trypanosoma brucei. Arch. Schiffs. Trop. Leipzig 1919, 23:211-226.
28. Corson J.F. The resistance of Trypanosoma rhodesiense to normal human blood-serum in relation to cyclical passage through tsetse-flies. J. Trop. Med. 1933, 36:365-367.
29. Lester H.M.O. The characteristics of some Nigerian strains of the polymorphic trypanosomes. Ann. Trop. Med. Parasitol. 1933, 27:361-395.
30. Manson P.T. Experimental proof of the mosquito-malaria theory. Br. Med. J. 1900, 2:949-951.
31. Schüffner W.A.P., et al. Pathology: experimental malaria with protracted incubation. Proc. R. Acad. Sci. Amst. 1929, 32:903-911.
32. Eyles D.E., et al. Vivax-type malaria parasite of macaques transmissible to man. Science 1960, 131:1812-1813.
33. Knowles R., Das Gupta B.M. A study of monkey-malaria, and its experimental transmission to man. Ind. Med. Gaz. 1932, 67:301-320.
34. Rodhain J. Les plasmodium des anthropoids de l'Afrique central et leurs relations avec les Plasmodium humains. Ann. Soc. Belge. Med. Trop. 1993, 19:563-572.
35. Contacos P.G., et al. Transmission of Plasmodium schwetzi from the chimpanzee to man by mosquito bite. Am. J. Trop. Med. Hyg. 1970, 19:190-195.
36. Aberle S.D. Primate Malaria 1945, National Academies.
37. Entamoeba histolytica (Schaudinn 1903). Parasitic Diseases 1995, 151-159. Springer. 3rd edn. D.D. Despommier (Ed.).
38. Westphal A. Betrachtungen und experimentelle Untersuchungen zur Virulenz der Entamoeba histolytica beim Menschen. Arch. Schiffs. Tropenhyg. Leipzig 1937, 41:262-279.
39. Maggiore S. Contributo allo studio etio-patogenetico delle infezioni du Leishmania. Pediatria 1925, 33:169.
40. Thomson J.G. The question of immunity in man to protozoal diseases. Proc. R. Soc. Med. 1931, 24:9-21.
41. Kobets T., et al. Leishmaniasis: prevention, parasite detection and treatment. Cur. Med. Chem. 2012, 19:1443-1474.
42. Chappell C.L., et al. Cryptosporidium hominis: experimental challenge of healthy adults. Am. J. Trop. Med. Hyg. 2006, 75:851-857.
43. Chappell C.L., et al. Cryptosporidium meleagridis: infectivity in healthy adult volunteers. Am. J. Trop. Med. Hyg. 2011, 85:238-242.
44. Striepen B. Time to tackle cryptosporidiosis. Nature 2013, 503:189-191.
45. Lanceley F., McEntegart M.G. Trichomonas vaginalis in the male the experimental infection of a few volunteers. Lancet 1953, 261:668-671.
46. Barlow C.H., Meleney H.E. A voluntary infection with Schistosoma haematobium. Am. J. Trop. Med. 1949, 29:79-87.
47. Haas W., van de Roemer A. Invasion of the vertebrate skin by cercariae of Trichobilharzia ocellata: penetration processes and stimulating host signals. Parasitol. Res. 1998, 84:787-795.
48. Kobayashi H. Studies in the development of Diphyllobothrium mansoni (Cobbold, 1882) Joyeux, 1928. III. Experimental studies on the infection by the mature procercoid. J. Med. Assoc. Formosa 1931, 30:16-39.
49. Mueller J.F., Coulston F. Experimental human infection with the Sparganum larva of Spirometra mansonoides (Mueller, 1935). Am. J. Trop. Med. 1941, 21:399-425.
50. Barlow C.H. The life cycle of the human intestinal fluke Fasciolopsis buski (Lankester). Am. J. Hyg. Monogr. Ser. 1925, 4:1-98.
51. Barlow C.H. Experimental ingestion of the ova of Fasciolopsis buski; also the ingestion of adult Fasciolopsis buski for the purpose of artificial infestation. J. Parasitol. 1921, 8:40-44.
52. Andersen K.I., et al. A review of freshwater species of Diphyllobothrium with redescriptions and the distribution of D. dendriticum (Nitzsch, 1824) and D. ditremum (Creplin, 1825) from North America. Can. J. Zool. 1987, 65:2216-2228.
53. Mayberry L.F. The infectious nature of parasitology. J. Parasitol. 1996, 82:856-864.
54. Freedman D.O. Experimental infection of human subjects with Strongyloides species. Rev. Infect. Dis. 1991, 13:1221-1226.
55. Sandground J.H. Some studies on susceptibility, resistance, and acquired immunity to infection with Strongyloides stercoralis (Nematoda) in dogs and cats. Am. J. Hyg. 1928, 8:507-538.
56. Faust E.C. Experimental studies on human and primate species of Strongyloides. II. The development of Strongyloides in the experimental host. Am. J. Hyg. 1933, 18:114-132.
57. Desportes C. Sur Strongyloides stercoralis (Bavay 1876) et sur les Strongyloides de Primates. Ann. Parasitol. 1945, 20:160-190.
58. Tanaka H. Experimental and epidemiological studies on strongyloidiasis of Amami Oshima island. Jpn. J. Exp. Med. 1958, 28:159-182.
59. Wang P.Y., et al. A ten-year observation on experimental-infection of periodic Brugia malayi in man. J. Trop. Med. Hyg. 1994, 97:269-276.
60. Grove D.I. A History of Human Helminthology 1990, CABI.
61. Dobell C. Researches on the intestinal protozoa of monkeys and man. V. The Endolimax of macaques. Parasitology 1933, 25:436-467.
62. Dobell C. Researches on the intestinal protozoa of monkeys and man. VI. Experiments with the trichomonads of man and the macaques. Parasitology 1934, 26:531-577.
63. Dobell C. Researches on the intestinal protozoa of monkeys and man. VII. On the Enteromonas of macaques and Embadomonas intestinalis. Parasitology 1935, 27:504-592.
64. Dobell C. Researches on the intestinal protozoa of monkeys and man. VIII. An experimental study of some simian strains of 'Entamoeba coli'. Parasitology 1936, 28:541-593.
65. Dobell C. Researches on the intestinal protozoa of monkeys and man. X. The life-history of Dientamoeba fragilis: observations, experiments, and speculations. Parasitology 1940, 32:417-461.
66. Young M.D. Attempts to transmit human Balantidium coli. Am. J. Trop. Med. 1950, 30:71-72.
67. Kean B.H., et al. Tropical Medicine and Parasitology: Classic Investigations. Volume 1 1978, Cornell University Press.
68. Štěrba J., Dyková I. Symptomatology of taeniasis caused by Taenia saginata. Folia Parasitol. 1979, 26:281-284.
69. Chao D., et al. Experimental infection in a human subject by a possibly undescribed species of Taenia in Taiwan. J. Helminthol. 1988, 62:235-242.
70. Leiper R.T. Some experiments and observations on the longevity of Diphyllobothrium infections. J. Helminthol. 1936, 14:127-130.
71. Tarasov V. De l'immunité acquise envers le bothriocéphale, Diphyllobothrium latum (L.). Ann. Parasitol. Hum. Com. 1937, 15:524-528.
72. Dick T.A., et al. Diphyllobothriasis: update on human cases, foci, patterns and sources of human infections and future considerations. Southeast Asian J. Trop. Med. Public Health 2001, 32:59-76.
73. Curtis M.A., Bylund G. Diphyllobothriasis: fish tapeworm disease in the circumpolar north. Arctic Med. Res. 1991, 50:18-25.
74. Kuchta, R. et al. (in press) Diphyllobothrium, Diplogonoporus and Spirometra. In Biology of Foodborne Parasites. Section III Important Foodborne Parasites (Xiao, L. et al., eds), Food Microbiology Series (Liu, D., series ed.), CRC Press.
75. Cooper P.J., Figuieredo C.A. Immunology of Ascaris and immunomodulation. Ascaris: the Neglected Parasite 2013, 3-19. Elsevier Science. C. Holland (Ed.).
76. Brudastov A.N., et al. Clinical picture of the migration phase of ascariasis in self-infection. Med. Parazitol. (Mosk) 1971, 40:165-168.
77. Ockert G. Epidemiology of Dientamoeba fragilis Jepps et Dobell, 1918. 2. Test on transfer of species with Enterobius eggs. J. Hyg. Epidemiol. Microbiol. Immunol. 1972, 16:222-224.
78. Beer R.J.S. Relationship between Trichuris trichiura (Linnaeus, 1758) of man and Trichuris suis (Schrank, 1788) of pig. Res. Vet. Sci. 1976, 20:47-54.
79. Summers R.W., et al. Trichuris suis therapy in Crohn's disease. Gut 2005, 54:87-90.
80. Broadhurst M.J., et al. IL-22(+) CD4(+) T cells are associated with therapeutic Trichuris trichiura infection in an ulcerative colitis patient. Sci. Transl. Med. 2010, 2:60ra88.
81. Turton J.A. IgE, parasites and allergy. Lancet 1976, 308:686.
82. Ashford R.W., Crewe W. The Parasites Of Homo Sapiens: An Annotated Checklist of Protozoa, Helminths and Arthropods for which we are Home 2003, Taylor & Francis. 2nd edn.
83. Mortimer K., et al. Dose-ranging study for trials of therapeutic infection with Necator americanus in humans. Am. J. Trop. Med. Hyg. 2006, 75:914-920.
84. Feary J., et al. Safety of hookworm infection in individuals with measurable airway responsiveness: a randomized placebo-controlled feasibility study. Clin. Exp. Allergy 2009, 39:1060-1068.
85. Tilp C., et al. Prerequisites for the pharmaceutical industry to develop and commercialise helminths and helminth-derived product therapy. Int. J. Parasitol. 2013, 43:319-325.
86. Aoyama H., et al. An inverse relationship between autoimmune liver diseases and Strongyloides stercoralis infection. Am. J. Trop. Med. Hyg. 2007, 76:972-976.